N NORAC PHARMA Trademark

Trademark Overview

On Friday, March 16, 2001, a trademark application was filed for N NORAC PHARMA with the United States Patent and Trademark Office. The USPTO has given the N NORAC PHARMA trademark a serial number of 78053447. The federal status of this trademark filing is REGISTERED AND RENEWED as of Thursday, March 8, 2018. This trademark is owned by Norac Company, Inc., The. The N NORAC PHARMA trademark is filed in the Pharmaceutical Products category with the following description:

Bulk pharmaceuticals, namely, active and excipient chemical ingredients promoted and sold for further value added treatment in the pharmaceutical manufacturing industry, and organic chemical intermediates promoted and sold for value added treatment in the pharmaceutical manufacturing industry
n norac pharma

General Information

Serial Number78053447
Word MarkN NORAC PHARMA
Filing DateFriday, March 16, 2001
Status800 - REGISTERED AND RENEWED
Status DateThursday, March 8, 2018
Registration Number3360335
Registration DateTuesday, December 25, 2007
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, March 12, 2002

Trademark Statements

Goods and ServicesBulk pharmaceuticals, namely, active and excipient chemical ingredients promoted and sold for further value added treatment in the pharmaceutical manufacturing industry, and organic chemical intermediates promoted and sold for value added treatment in the pharmaceutical manufacturing industry
Indication of Colors claimedColor is not claimed as a feature of the mark.
NOT AVAILABLE"PHARMA"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, March 22, 2001
Primary Code005
First Use Anywhere DateThursday, January 17, 2002
First Use In Commerce DateThursday, January 17, 2002

Trademark Owner History

Party NameS & B PHARMA, LLC
Party Type32 - New Owner After Registration
Legal Entity Type16 - Limited Liability Company
AddressAZUSA, CA 91702-3232
Party NameS & B PHARMA, INC.
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressAZUSA, CA 91702
Party NameNORAC, INC.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressAZUSA, CA 917020706
Party NameNORAC, INC.
Party Type21 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressAZUSA, CA 917020706
Party NameNorac Company, Inc., The
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressAzusa, CA 917020706
Party NameNorac Company, Inc., The
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressAzusa, CA 917020706

Trademark Events

Event DateEvent Description
Wednesday, March 28, 2001CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, July 5, 2001ASSIGNED TO EXAMINER
Thursday, July 12, 2001NON-FINAL ACTION MAILED
Monday, August 6, 2001CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, September 27, 2001APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 20, 2002NOTICE OF PUBLICATION
Tuesday, March 12, 2002PUBLISHED FOR OPPOSITION
Thursday, March 28, 2002EXTENSION OF TIME TO OPPOSE RECEIVED
Saturday, July 27, 2002OPPOSITION INSTITUTED NO. 999999
Friday, November 29, 2002PAPER RECEIVED
Friday, July 14, 2006OPPOSITION TERMINATED NO. 999999
Tuesday, August 29, 2006NOA MAILED - SOU REQUIRED FROM APPLICANT
Monday, January 8, 2007SOU TEAS EXTENSION RECEIVED
Monday, January 8, 2007SOU EXTENSION 1 FILED
Thursday, March 15, 2007SOU EXTENSION 1 GRANTED
Wednesday, August 8, 2007TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, August 8, 2007ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, August 28, 2007USE AMENDMENT FILED
Wednesday, August 29, 2007TEAS STATEMENT OF USE RECEIVED
Monday, September 10, 2007STATEMENT OF USE PROCESSING COMPLETE
Monday, October 15, 2007ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, November 15, 2007ASSIGNED TO LIE
Friday, November 16, 2007LAW OFFICE REGISTRATION REVIEW COMPLETED
Tuesday, December 25, 2007REGISTERED-PRINCIPAL REGISTER
Wednesday, October 30, 2013TEAS SECTION 8 & 15 RECEIVED
Wednesday, October 30, 2013REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
Thursday, November 14, 2013CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, November 15, 2013REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Friday, November 15, 2013NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Thursday, March 6, 2014TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, March 6, 2014ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, September 17, 2014AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Sunday, December 25, 2016COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Tuesday, February 20, 2018TEAS SECTION 8 & 9 RECEIVED
Wednesday, March 7, 2018CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, March 8, 2018REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Thursday, March 8, 2018REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Thursday, March 8, 2018NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Friday, November 27, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, November 27, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, November 27, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, November 27, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, November 27, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, December 13, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, December 13, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, December 13, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, November 20, 2024AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

Related Keywords

pharma norac added value treatment pharmaceutical industry manufacturing promoted sold chemical pharmaceuticals